Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; an older notice about government funding and the previous Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice was added, indicating NIH operations status, and the site revision tag was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedNat Commun publication entry for Fruquintinib plus sintilimab was added and updated from 'Online ahead of print' to the final citation, with related metadata such as a revision tag (v3.4.0) and 'Last Update Submitted that Met QC Criteria'. A new 'Show glossary' control was introduced, and 'No FEAR Act Data' information was added.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations now include Shanghai Municipality and a new publication citation for Fruquintinib plus sintilimab (Nat Commun 2025). The record revision is updated to v3.3.3, replacing the prior v3.3.2 entry.SummaryDifference0.3%

- Check91 days agoChange DetectedAdded a note that PubMed publications are automatically populated from PubMed and may not all relate to the study. The page revision was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.